NDC 72934-1061

DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5%

Dapsone 6% / Niacinamide 2% / Spironolactone 5%

DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Niacinamide; Dapsone; Spironolactone.

• Product ID: 72934-1061_888b2203-46a0-d599-e053-2995a90a7de1
• NDC: 72934-1061
• Product Type: Human Prescription Drug
• Proprietary Name: DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5%
• Generic Name: Dapsone 6% / Niacinamide 2% / Spironolactone 5%
• Dosage Form: Gel
• Route of Administration: TOPICAL
• Marketing Start Date: 2019-05-11
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sincerus Florida, LLC
• Substance Name: NIACINAMIDE; DAPSONE; SPIRONOLACTONE
• Active Ingredient Strength: 2 g/100g; g/100g; g/100g
• Pharm Classes: Sulfone [EPC],Sulfones [CS],Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 72934-1061-2

30 g in 1 BOTTLE, PUMP (72934-1061-2)

• Marketing Start Date: 2019-05-11
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72934-1061-2 [72934106102]

DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5% GEL

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: GM
• Marketing Start Date: 2019-05-11

Drug Details

Active Ingredients

Ingredient	Strength
NIACINAMIDE	2 g/100g

OpenFDA Data

• SPL SET ID: 888b2203-469f-d599-e053-2995a90a7de1
• Manufacturer:
  • Sincerus Florida, LLC
• UNII:
  • 25X51I8RD4
  • 27O7W4T232
  • 8W5C518302

Pharmacological Class

• Sulfone [EPC]
• Sulfones [CS]
• Aldosterone Antagonist [EPC]
• Aldosterone Antagonists [MoA]
• Sulfone [EPC]
• Sulfones [CS]
• Aldosterone Antagonist [EPC]
• Aldosterone Antagonists [MoA]